ATNM
Actinium Pharmaceuticals Inc
Halal Rating :
Last Price
$1.39
Last updated:
Market Cap
-
7D Change
9.92%
1 Year Change
-73.92%
Company Overview
Industries
Exchange
Next Earnings Date
Actinium Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing targeted radiotherapies for patients with unmet needs in cancer care. The company's primary focus is on developing its lead product candidate, Iomab-B, which is designed to target and kill cancer cells while sparing healthy cells.
The company is currently in research and development phase, with minimal to no revenue from operations, as it works to develop and commercialize its drug candidates through clinical trials.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|
Company Impact
Help us evaluate Actinium Pharmaceuticals Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.